Skip to main content
C

China Health Group Inc. — Investor Relations & Filings

Ticker · 8225 ISIN · KYG2117N1088 LEI · 254900PWX6498SJFLW25 HKEX Human health and social work activities
Open in API
Filings indexed 992 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 8225

About China Health Group Inc.

http://www.chgi.net

China Health Group Inc. is an integrated healthcare platform providing solutions to pharmaceutical enterprises and medical institutions, driven by Real-World Study (RWS), Real-World Data (RWD), and Artificial Intelligence (AI). The company's core business encompasses four synergistic segments: Clinical Research and Product Promotion (CRSO), Hospital Operation and Management, Specialty Departments and Telemedicine, and Rehabilitation and Medical Tourism. Services include RWS-driven clinical research, scientific promotion, drug formulation and Active Pharmaceutical Ingredient (API) development, and technology transfer. The company also specializes in managing hospitals and internet medical facilities, developing research-oriented specialty services (e.g., mental rehabilitation, chronic disease prevention), and offering medical tourism projects. It provides full-chain support from R&D to clinical trials and registration for a global client base, including major international pharmaceutical companies.

Recent filings

Filing Released Lang Actions
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025
Regulatory Filings
2026-04-29 English
ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2025
Regulatory Filings
2026-04-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a standardized monthly return (Form FF301) filed with the Hong Kong Stock Exchange under Chapter 19B of the Listing Rules. It reports detailed movements in share capital, issued shares, share options, public float confirmation, and related confirmations. It is neither an earnings release nor a shareholder meeting presentation, nor a structured financial report like an annual or interim report. Instead, it is a routine regulatory submission that does not correspond to any other specific category. Therefore, it falls under the fallback “Regulatory Filings” category.
2026-04-02 English
Voluntary Announcement - Supplementary Information Regarding the 2025 Annual Results and Future Development Strategy
Management Reports Classification · 1% confidence The document is a voluntary announcement by a Hong Kong‐listed company providing supplementary management commentary on the full‐year 2025 results—detailing core operations, accounting provisions, strategic deployments, and future outlook. It is not the primary earnings release (ER), a short notice of report publication (RPA), or other transaction/board update. Instead it serves as management’s detailed explanation of financial performance, business trends, and strategy. This aligns with the definition of a Management Report (MDA).
2026-04-02 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Annual Report Classification · 1% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025' and contains comprehensive financial statements, including the Consolidated Statement of Profit or Loss, Consolidated Statement of Financial Position, and Notes to the Consolidated Financial Statements. While it is labeled as an 'Annual Results Announcement', it provides the full financial data and disclosures typical of an annual report for the fiscal year. Given the document length and the inclusion of substantive financial statements, it is classified as an Annual Report (10-K). FY 2025
2026-04-01 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Annual Report Classification · 1% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025' and contains comprehensive financial statements, including the Consolidated Statement of Profit or Loss, Consolidated Statement of Financial Position, and Notes to the Consolidated Financial Statements. Although it is labeled as an 'Annual Results Announcement', it provides the full financial data and analysis for the fiscal year, which aligns with the definition of an Annual Report (10-K) in the context of financial reporting standards for listed companies on the Hong Kong Stock Exchange. FY 2025
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.